UNIVERSITY OF EDINBURGH
- Country
- 🇬🇧United Kingdom
- Ownership
- -
- Established
- 1583-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.ed.ac.uk
Clinical Trials
370
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (206 trials with phase data)• Click on a phase to view related trials
Intermittent Cold Exposure and Brown Adipose Tissue Hyperplasia
- Conditions
- 18F-FDG PET/CTCold ExposureBrown Adipose Tissue
- First Posted Date
- 2025-07-02
- Last Posted Date
- 2025-07-09
- Lead Sponsor
- University of Edinburgh
- Target Recruit Count
- 12
- Registration Number
- NCT07048405
- Locations
- 🇬🇧
Royal Infirmary of Edinburgh, Edinburgh, United Kingdom
Mechanisms of Myocardial Injury and Ischemia in Patients With Rapid Atrial Fibrillation
- Conditions
- Atrial Fibrillation (AF)
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- University of Edinburgh
- Target Recruit Count
- 300
- Registration Number
- NCT06951100
- Locations
- 🇬🇧
Royal Infirmary of Edinburgh, Edinburgh, East Of England, United Kingdom
Developing a Brief Intervention to Communicate Cardiovascular Risk to Patients Presenting to the Emergency Department with Chest Pain: a Co-Production Approach. Phase 2.
- Conditions
- Cardiovascular Diseases
- First Posted Date
- 2025-03-30
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- University of Edinburgh
- Target Recruit Count
- 118
- Registration Number
- NCT06903442
Dual Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)
- Conditions
- Large Vessel VasculitisGiant Cell Arteritis (GCA)Takayasu Arteritis
- Interventions
- First Posted Date
- 2025-03-20
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- University of Edinburgh
- Target Recruit Count
- 60
- Registration Number
- NCT06887062
- Locations
- 🇬🇧
University of Edinburgh, Edinburgh, United Kingdom
A Study on Bedside Formate Assay as a Diagnostic Tool in Methanol Poisoning
- Conditions
- Metabolic Acidosis
- First Posted Date
- 2025-03-18
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- University of Edinburgh
- Target Recruit Count
- 6120
- Registration Number
- NCT06881641
- Locations
- 🇧🇩
Chittagong Medical College Hospital, Chittagong, Bangladesh
🇧🇩Mag Osmania Medical College Hospital Sylhet, Sylhet, Bangladesh
🇮🇳PGIEMR, Chandigarh, India
- Prev
- 1
- 2
- 3
- 4
- 5
- 74
- Next
News
Novel Non-Hormonal Male Contraceptive "Adam" Shows Two-Year Efficacy in Clinical Trials
A new non-hormonal male contraceptive implant called Adam has demonstrated effectiveness for at least two years in initial clinical trials, with no sperm detected in participants reaching the 24-month mark.
Antidepressants Linked to Increased Risk of Sudden Cardiac Death, Danish Study Reveals
New research from Denmark shows antidepressant use is associated with an increased risk of sudden cardiac death, with risk rising based on duration of exposure.
AI Advances in Breast Cancer Detection: New Technologies Show Promise for Earlier Diagnosis
AI technology developed at Washington University can analyze sequential mammograms to identify subtle tissue changes, predicting breast cancer risk 2.3 times more accurately than standard methods.
Breakthrough: Combined Drug Therapy Shows Near-Complete Elimination of Liver Cancer in Study
Scottish researchers discover that combining cladribine with lenvatinib nearly eradicates hepatocellular carcinoma tumors in groundbreaking preclinical study led by Professor Tom Bird.
Early Aortic Valve Intervention Fails to Show Benefit in Asymptomatic Patients with Severe Aortic Stenosis and Myocardial Fibrosis
A randomized clinical trial involving 224 patients revealed that early aortic valve intervention did not significantly reduce the composite outcome of all-cause death or unplanned aortic stenosis-related hospitalization.
EVOLVED Trial: Early Aortic Valve Replacement Fails to Show Mortality Benefit in Asymptomatic Patients with Fibrosis
The EVOLVED study found that early aortic valve replacement (AVR) in asymptomatic patients with myocardial fibrosis did not reduce all-cause mortality or unplanned aortic stenosis-related hospitalizations.
SGLT-2 Inhibitors Linked to Reduced Dementia Risk in Type 2 Diabetes Study
A new study suggests that Sodium-glucose cotransporter-2 (SGLT-2) inhibitors, used for treating type 2 diabetes, are associated with a lower risk of developing dementia.